fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Service...

FDA Recall #D-1047-2023 — Class II — July 17, 2023

Recall #D-1047-2023 Date: July 17, 2023 Classification: Class II Status: Terminated

Product Description

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3

Reason for Recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recalling Firm

Central Admixture Pharmacy Services Inc — San Diego, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,216 syringes

Distribution

Nationwide in the USA

Code Information

Lot: 17-270771, Exp. 7/19/2023; 17-271134, Exp. 7/25/2023; 17-271577, Exp. 8/1/2023; 17-271745, Exp. 8/3/2023; 17-272026, Exp. 8/9/2023; 17-272345, Exp. 8/15/2023; 17-272615, Exp. 8/20/2023; 17-273668, Exp. 9/6/2023.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated